UK Trade & Investment has brought together representatives from throughout the UK Life Science industry with international trade and investment experience to form a marketing board.
The Board steer the direction of the strategy to maximise business opportunities and play an essential role in stimulating thought leadership within the industry about the strategy
The Board's responsibilities include looking at which international territories will offer the greatest opportunity for UK business and then developing a shared marketing charter to help promote the UK's Life Science sectors consistently and persuasively around the world.
The members will also look to drive partnership and share resources between business, trade associations, cluster and research organisations, universities and Government.
The members have developed a shared vision of what success will look like in five years time. This will be refined regularly as work progresses; it is a guiding foundation for both the Board and wider stakeholders.
To move on implementing the marketing strategy, the Board has set up six work streams which will be made up of board members and those in the wider UK sector to drive specific areas of Life Science expertise and country-focused marketing forward.
The Board is chaired by Chris Brinsmead Chair of AstraZeneca Pharma UK. Click Board members to view profiles of all 11 members.